Barclays Capital Inc. v. Theflyonthewall.com, Inc.

Dell Technologies Announces Pricing Terms for Cash Tender Offers for Certain Outstanding Debt Securities

Retrieved on: 
Monday, December 20, 2021

Therefore, Dell does not expect to accept for purchase any tenders of Securities at Acceptance Priority Levels 3 through 6.

Key Points: 
  • Therefore, Dell does not expect to accept for purchase any tenders of Securities at Acceptance Priority Levels 3 through 6.
  • The information agent and tender agent for the Offers is Global Bondholder Services Corporation (the "Tender Agent").
  • The solicitation of offers to sell the Securities is only being made pursuant to the terms of the Offer to Purchase.
  • Dell Technologies, Dell, EMC and Dell EMC are trademarks of Dell Inc. or its subsidiaries.

Dell Technologies Announces Early Results and Increase of Tender Cap and Maximum Tender Amount for Cash Tender Offers for Certain Outstanding Debt Securities

Retrieved on: 
Monday, December 20, 2021

The Amended Tender Cap represents the maximum aggregate principal amount of such series of Securities that will be purchased.

Key Points: 
  • The Amended Tender Cap represents the maximum aggregate principal amount of such series of Securities that will be purchased.
  • Therefore, Dell does not expect to accept for purchase any tenders of Securities at Acceptance Priority Levels 3 through 6.
  • As a result, tendered Securities may not be withdrawn, except in certain limited circumstances where additional withdrawal rights are required by law (as determined by Dell).
  • Barclays Capital Inc. and BofA Securities, Inc. are acting as the dealer managers for the Offers (together, the "Dealer Managers").

Legend Biotech Corporation Announces Pricing of Public Offering

Retrieved on: 
Thursday, December 16, 2021

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that it has priced an underwritten public offering of 7,500,000 American depositary shares (ADSs), each representing two ordinary shares, at a public offering price of $40.00 per ADS, for total gross proceeds of approximately $300.0 million.

Key Points: 
  • Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that it has priced an underwritten public offering of 7,500,000 American depositary shares (ADSs), each representing two ordinary shares, at a public offering price of $40.00 per ADS, for total gross proceeds of approximately $300.0 million.
  • In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 ADSs at the public offering price, less underwriting discounts and commissions.
  • Morgan Stanley, J.P. Morgan, Jefferies, Piper Sandler & Co. and Barclays are serving as joint book-running managers for the offering.
  • The ADSs are being offered by Legend Biotech pursuant to an effective shelf registration statement that was previously filed with the Securities and Exchange Commission (SEC).

Legend Biotech Corporation Announces Proposed Public Offering

Retrieved on: 
Tuesday, December 14, 2021

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that it intends to offer and sell $300.0 million of American Depositary Shares (ADSs), each representing two ordinary shares, in an underwritten public offering.

Key Points: 
  • Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that it intends to offer and sell $300.0 million of American Depositary Shares (ADSs), each representing two ordinary shares, in an underwritten public offering.
  • All ADSs to be sold in the proposed offering will be offered by Legend Biotech.
  • Legend Biotech also intends to grant the underwriters a 30-day option to purchase up to an additional $45.0 million of ADSs sold in the public offering at the public offering price, less underwriting discounts and commissions.
  • These statements include, but are not limited to, statements relating to the proposed public offering.

Power & Digital Infrastructure Acquisition II Corp. Closes $287.5 Million Initial Public Offering

Retrieved on: 
Tuesday, December 14, 2021

Total gross proceeds from the offering were $287,500,000, before deducting underwriting discounts and commissions and other offering expenses.

Key Points: 
  • Total gross proceeds from the offering were $287,500,000, before deducting underwriting discounts and commissions and other offering expenses.
  • The units are listed on The Nasdaq Stock Market LLC and trade under the ticker symbol XPDBU.
  • Each unit consists of one share of Class A common stock of the Company and one-half of one redeemable warrant.
  • This press release contains statements that constitute forward-looking statements, including with respect to the proposed initial public offering and the anticipated use of the net proceeds.

The Growth for Good Acquisition Corporation Announces Closing of $253 Million Initial Public Offering

Retrieved on: 
Tuesday, December 14, 2021

The Growth for Good Acquisition Corporation (Growth for Good or the Company), a newly formed and differentiated blank check company, today announced the closing of its initial public offering of 25,300,000 units, which included the full exercise of the underwriters over-allotment option, at $10.00 per unit.

Key Points: 
  • The Growth for Good Acquisition Corporation (Growth for Good or the Company), a newly formed and differentiated blank check company, today announced the closing of its initial public offering of 25,300,000 units, which included the full exercise of the underwriters over-allotment option, at $10.00 per unit.
  • The total gross proceeds of the initial public offering amounts to $253,000,000.
  • The units began trading on the Nasdaq Global Market (Nasdaq) under the ticker symbol GFGDU on Friday, December 10, 2021.
  • The Growth for Good team is further supported by venture capitalists, public market executives and investors, and leaders with significant buy- and sell- side experience in the execution of mergers and transactions.

Domtar Corporation Announces Termination of Consent Solicitations Relating to Its 6.25% Senior Notes Due 2042 and 6.75% Senior Notes Due 2044

Retrieved on: 
Monday, December 13, 2021

Domtar Corporation (the Company) today announced that it has terminated its previously announced solicitations of consents (the "Consent Solicitations") relating to its outstanding 6.25% Senior Notes due 2042 (CUSIP No.

Key Points: 
  • Domtar Corporation (the Company) today announced that it has terminated its previously announced solicitations of consents (the "Consent Solicitations") relating to its outstanding 6.25% Senior Notes due 2042 (CUSIP No.
  • US257559AJ34) (the 2042 Notes) and 6.75% Senior Notes due 2044 (CUSIP No.
  • US257559AK07) (the 2044 Notes and, together with the 2042 Notes, the Notes), whereby the Company solicited consents of holders of the Notes to certain proposed amendments to the senior indenture governing the Notes.
  • The Consent Solicitations were subject to the conditions set forth in the Companys Consent Solicitation Statement, dated December 2, 2021.

M Partners Inc. Initiates Analyst Coverage on Playmaker

Retrieved on: 
Monday, December 13, 2021

Playmaker Capital Inc. (TSX-V: PMKR, OTCQX: PMKRF) (the Company) (Playmaker), the digital sports media company that delivers authentic content experiences through its portfolio of sports media and technology brands, announced today that M Partners Inc. ("M Partners") has initiated analyst coverage on the Company.

Key Points: 
  • Playmaker Capital Inc. (TSX-V: PMKR, OTCQX: PMKRF) (the Company) (Playmaker), the digital sports media company that delivers authentic content experiences through its portfolio of sports media and technology brands, announced today that M Partners Inc. ("M Partners") has initiated analyst coverage on the Company.
  • M Partners initial research report and all future reports (if any) may be obtained directly from M Partners.
  • Please note that any opinions, estimates or forecasts regarding the performance of Playmaker and its management made by M Partners are theirs alone and do not represent the opinions, estimates or forecasts of Playmaker or its management.
  • Specific forward-looking information contained in this press release includes, but is not limited to: statements concerning any future analyst reports to be published by M Partners and the future coverage of the Company by M Partners generally.

Pegasus Digital Mobility Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on December 13, 2021

Retrieved on: 
Friday, December 10, 2021

No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Key Points: 
  • No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
  • The Class A ordinary shares and warrants that are separated will trade on the New York Stock Exchange under the symbols PGSS and PGSS.WS, respectively.
  • Those units not separated will continue to trade on the New York Stock Exchange under the symbol PGSS.U.
  • Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Companys transfer agent, in order to separate the units into Class A ordinary shares and warrants.

Power & Digital Infrastructure Acquisition II Corp. Announces Pricing of $250 Million Initial Public Offering

Retrieved on: 
Friday, December 10, 2021

The units will be listed on The Nasdaq Stock Market LLC and trade under the ticker symbol XPDBU beginning December 10, 2021.

Key Points: 
  • The units will be listed on The Nasdaq Stock Market LLC and trade under the ticker symbol XPDBU beginning December 10, 2021.
  • Each unit consists of one share of Class A common stock of the Company and one-half of one redeemable warrant.
  • The offering is expected to close on December 14, 2021, subject to customary closing conditions.
  • This press release contains statements that constitute forward-looking statements, including with respect to the proposed initial public offering and the anticipated use of the net proceeds.